49702-214 : Retrovir 300 mg Oral Tablet

Labeler: Viiv Healthcare Company
Product Type: Human Prescription Drug
Drug Name:  Retrovir
Dosage Form: Oral Tablet, Film Coated
Application #: NDA020518
Rev. Date: 


Markings: GX;CW3;300
Shapes:  Round
Colors:  White
Size (mm): 10
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

GX CW3 300: (49702-214) Retrovir 300 mg Oral Tablet by Viiv Healthcare Company
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 49702-214-18: 60 TABLET, FILM COATED IN 1 BOTTLE (49702‑214‑18)

Active Ingredients:

  • Zidovudine

Dosage Strength:

  • 300 mg

Inactive Ingredients:

  • Hypromelloses
  • Magnesium Stearate
  • Cellulose, Microcrystalline
  • Polyethylene Glycols
  • Sodium Starch Glycolate Type a Potato
  • Titanium Dioxide

Pharmaceutical Classes:

  • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Nucleoside Analog [Chemical/Ingredient]
  • Nucleoside Reverse Transcriptase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 49702-211 Retrovir 100 mg Oral Capsule by Viiv Healthcare Company
  • 49702-212 Retrovir 10 mg/ml Oral Syrup by Viiv Healthcare Company
  • 49702-213 Retrovir 10 mg/ml Intravenous Injection, Solution by Viiv Healthcare Company
  • 63379-026 Retrovir 10 mg/ml Intravenous Injection, Solution by Glaxo Operations Uk Ltd


Scan the QR code below to easily reference this data in the future:

NDC 49702-214 QR Code

< Prev: 49702-213Next: 49702-215 >

Related Discussions:

During my Lamivudine/Zidovudine and Efarenz medication, take ginseng?
During my Lamivudine/Zidovudine and Efarenz medication as a HIV patient take Ginseng and other kind of natural supliment...

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.